A recent study has found deep neural networks (DDNs)—a category of artificial intelligence (AI) algorithm—capable of forecasting cardiac pump function from standard angiography videos, providing accurate left ventricular ejection fraction (LVEF) predictions with strong correlations to echocardiographic LVEF measurements, the standard non-invasive clinical approach.
Coronary heart disease is the leading cause of adult death worldwide. The coronary angiography procedure provides the clinical standard diagnostic assessment for nearly all related clinical decision-making, from medications to coronary bypass surgery. In many cases, quantifying left ventricular ejection fraction (LVEF) at the time of coronary angiography is critical to optimise clinical decision-making and treatment decisions, particularly when angiography is performed for potentially life-threatening acute coronary syndromes (ACS).
Since the left ventricle is the heart’s pumping centre, measuring the ejection fraction in the chamber provides critical information about the percentage of blood leaving the heart each time it squeezes. Presently, measuring LVEF during angiography requires an additional invasive procedure called left ventriculography—where a catheter is inserted into the left ventricle and contrast dye is injected—which carries additional risks and increases the contrast exposure.
Published today in JAMA Cardiology, the study’s senior author Geoff Tison (University of California San Francisco, San Francisco, USA) and first author Robert Avram (Montreal Heart Institute, Montreal, Canada) set out to determine whether DDNs could be used to predict cardiac pump (contractile) function from standard angiogram videos. They developed and tested a DNN called CathEF, to estimate LVEF from coronary angiograms of the left side of the heart.
“This study presents a novel method for assessing LVEF, an important measure of heart function, during any routine coronary angiography without requiring additional procedures or increasing cost,” said Avram. “LVEF is essential for making decisions during the procedure and for managing patient care.”
The researchers performed a cross-sectional study of 4,042 adult angiograms matched with corresponding transthoracic echocardiograms (TTEs) from 3,679 UCSF patients and trained a video-based neural network to estimate reduced LVEF (less than or equal to 40%) and to predict (continuous) LVEF percentage from standard angiograms videos of the left coronary artery.
The results showed that CathEF accurately predicted LVEF, with strong correlations to echocardiographic LVEF measurements, the standard noninvasive clinical approach. The model was also externally validated in real-world angiograms from the Ottawa Heart Institute in Ottawa, Canada. The algorithm performed well across different patient demographics and clinical conditions, including acute coronary syndromes and varying levels of renal function—patient populations that may be less well suited to receive the standard left ventriculogram procedure.
“This work demonstrates that AI technology has the potential to reduce the need for invasive testing and improve the diagnostic capabilities of cardiologists, ultimately improving patient outcomes and quality of life,” said Tison. “CathEF offers a novel approach that leverages data that is routinely collected during every angiogram to provide information that is not currently available to clinicians during angiography, effectively expanding the utility of medical data with AI and provides real-time LVEF information that informs clinical decision-making.”
Although the algorithm was trained on a large dataset of angiograms from UCSF and then separately validated in a dataset from the Ottawa Heart Institute, the investigators are undertaking further research to test this algorithm at the point-of-care and determine its impact on the clinical workflow in patients suffering heart attacks. To this end, a multicentre prospective validation study in patients with ACS is underway to compare the performance of CathEF and the left ventriculogram with TTEs performed within seven days of ACS.